patients
Sword Health cut a portion of its physical therapists last month, the company confirmed to BI.The startup aims to use AI to help increase the number of patients its physical therapists care for.Sword, which hit a $3 billion valuation earlier this year, could go public as soon as 2025. Sword…
By Deena Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain earlier this month. She is doing what she can to prevent the crippling attacks in her arms, legs and abdomen…
Most patients stop using Wegovy, Ozempic for weight loss within two years, analysis finds By Reuters
By Chad Terhune (Reuters) -Only one in four U.S. patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight loss were still taking the popular medications two years later, according to an analysis of U.S. pharmacy claims provided to Reuters that also showed a steady decline in use over time. The…
By Patrick Wingrove (Reuters) – Eli Lilly (NYSE:) on Friday said its popular weight-loss drug Zepbound helped resolve moderate to severe obstructive sleep apnea in up to 52% of patients in two late-stage trials. U.S.-based Lilly and Danish rival Novo Nordisk (NYSE:) are in a race to get their obesity…